A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China Released2026-05-31 14:05 business newsnewsweb article Read more on www.cnbc.com A Picture from image.cnbcfm.com Related items Published byCCNBC In one list NewsNews330,515 items
